易明醫藥(002826.SZ):以3060萬元收購內蒙古博斯泰企業51%股權
格隆匯8月13日丨易明醫藥(002826.SZ)公佈,公司以支付現金的方式收購內蒙古博斯泰企業管理服務有限公司(“標的公司”)股東王鍵澤持有的該公司51%股權,交易價格為人民幣3060萬元。此次收購完成後,公司持有標的公司51%股權。
標的公司作為區域醫藥推廣公司,終端覆蓋面廣、配送能力強,具有對公司現有產品的運作經驗,並簽署有大株紅景天注射液、注射用磷酸川芎嗪、地高辛注射液、注射用硫酸多粘菌素B、注射用多種維生素(12)等外部企業產品在內蒙古、遼寧(部分產品)區域內的推廣業務,發展規劃清晰,有助於加速公司在區域市場內的渠道拓展,資源整合。控股標的公司對公司現有產品在內蒙古、遼寧區域內的精細化發展有積極加速推動作用,吸納標的公司簽署的其他產品,對公司整體產品結構有良好的補充作用,未來具有較大的發展潛力和上升空間,對公司未來財務狀況和經營成果產生積極影響,符合公司戰略規劃和全體股東的利益。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.